English | 繁體

Search in the results

UM

Browse/Search Results:  1-6 of 6 Help

Selected(0)Clear Items/Page:    Sort:
Characterization of second primary malignancies post CAR T-cell therapy: real-world insights from the two global pharmacovigilance databases of FAERS and VigiBase Journal article
Shen, Junyi, Hu, Rong, Lin, Anqi, Jiang, Aimin, Tang, Bufu, Liu, Zaoqu, Cheng, Quan, Miao, Kai, Zhang, Jian, Luo, Peng. Characterization of second primary malignancies post CAR T-cell therapy: real-world insights from the two global pharmacovigilance databases of FAERS and VigiBase[J]. eClinicalMedicine, 2024, 73, 102684.
Authors:  Shen, Junyi;  Hu, Rong;  Lin, Anqi;  Jiang, Aimin;  Tang, Bufu; et al.
Favorite | TC[WOS]:8 TC[Scopus]:7 | Submit date：2024/07/04
Car-t  Faers  Myelodysplastic Syndromes  Second Primary Malignancy  T-cell Lymphoma  Vigibase  
Antibody Recognition of Human Epidermal Growth Factor Receptor-2 (HER2) Juxtamembrane Domain Enhances Anti-Tumor Response of Chimeric Antigen Receptor (CAR)-T Cells Journal article
Zhou, Guangyu, Fu, Shengyu, Zhang, Yunsen, Li, Shuang, Guo, Ziang, Ouyang, Defang, Ying, Tianlei, Lu, Yinying, Zhao, Qi. Antibody Recognition of Human Epidermal Growth Factor Receptor-2 (HER2) Juxtamembrane Domain Enhances Anti-Tumor Response of Chimeric Antigen Receptor (CAR)-T Cells[J]. Antibodies, 2024, 13(2), 45.
Authors:  Zhou, Guangyu;  Fu, Shengyu;  Zhang, Yunsen;  Li, Shuang;  Guo, Ziang; et al.
Favorite | TC[WOS]:0 TC[Scopus]:0  IF:3.0/4.7 | Submit date：2024/08/05
Her2  Monoclonal Antibody  Car-t Cell  Trastuzumab  
Targeting B7-H3 via chimeric antigen receptor T cells and bispecific killer cell engagers augments antitumor response of cytotoxic lymphocytes Journal article
Liu, Jie, Yang, Shuo, Cao, Bihui, Zhou, Guangyu, Zhang, Fengjuan, Wang, Yuan, Wang, Rixin, Zhu, Lipeng, Meng, Ya, Hu, Cong, Liang, Hui, Lin, Xu, Zhu, Kangshun, Chen, Guokai, Luo, Kathy Qian, Di, Lijun, Zhao, Qi. Targeting B7-H3 via chimeric antigen receptor T cells and bispecific killer cell engagers augments antitumor response of cytotoxic lymphocytes[J]. Journal of Hematology and Oncology, 2021, 14(1), 1-18.
Authors:  Liu, Jie;  Yang, Shuo;  Cao, Bihui;  Zhou, Guangyu;  Zhang, Fengjuan; et al.
Favorite | TC[WOS]:65 TC[Scopus]:69  IF:29.5/26.9 | Submit date：2021/03/04
B7-h3  Bike  Bispecific Antibody  Car t  Chimeric Antigen Receptor  Non-small Cell Lung Cancer  Pd-l1  
Novel chimeric antigen receptor T cells based on T-cell receptor-like antibodies Journal article
Zhao, Q.. Novel chimeric antigen receptor T cells based on T-cell receptor-like antibodies[J]. Blood Science, 2019, 144-147.
Authors:  Zhao, Q.
Favorite |   IF:1.5/1.4 | Submit date：2023/08/25
Antibody  CAR  T cell  TCR-like antibody  
Novel chimeric antigen receptor T cells based on T-cell receptor-like antibodies Journal article
Zhao, Qi. Novel chimeric antigen receptor T cells based on T-cell receptor-like antibodies[J]. Blood Science, 2019, 1(2), 144-147.
Authors:  Zhao, Qi
Favorite | TC[WOS]:5 TC[Scopus]:5  IF:1.5/1.4 | Submit date：2022/08/27
Antibody  Car  t Cell  Tcr-like Antibody  
T Cells Expressing Cars Directed Against HLA-0201 –Rmf WT-1 Peptide Complex Can Effectively Eradicate WT1+ A0201+ Tumor Cells in-Vitro Journal article
Kuo, T., Hasan, A., Zhao, Q., Selvakumar, A., Tassev, D., Cheung, N., O'Reilly, R.. T Cells Expressing Cars Directed Against HLA-0201 –Rmf WT-1 Peptide Complex Can Effectively Eradicate WT1+ A0201+ Tumor Cells in-Vitro[J]. Biology of Blood and Marrow Transplantation, 2014, S132-S133.
Authors:  Kuo, T.;  Hasan, A.;  Zhao, Q.;  Selvakumar, A.;  Tassev, D.; et al.
Favorite |   IF:4.300/4.400 | Submit date：2023/08/30
T cell  WT-1  TCR mimic CAR